WebThe Company. Biocure Technology Inc. is a biopharmaceutical company comprised of leading scientists specializing in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing Biosimilar technologies for cancer treatment. WebAt BioCure we provide all the services to manage and operate a profitable infusion suite within your practice. BioCure is a full-service pharmacy in addition to our management services expertise. This allows your patients …
BioCure Technology Inc. Lists on the Frankfurt Stock Exchange …
WebMay 24, 2024 · It seems insiders own a significant proportion of Biocure Technology Inc.. It has a market capitalization of just CA$29m, and insiders have CA$8.3m worth of shares in their own names. Webbiocure announced a breakthrough pre-clinical trial results for car-t cells treatment of acute leukemia Trial results demonstrated zero toxicity of the reengineered BioCure CAR-T … Biocure Technology Inc. is a biopharmaceutical company comprised … The Board of Directors of Biocure Technology Inc. (the “Company”) sets … VANCOUVER, British Columbia, February 8, 2024 -- Biocure Technology Inc. … sly cooper and the thievius raccoonus online
BioCure Technology Inc. Announces New President, Appointment …
WebJul 29, 2024 · The Board of Directors of Biocure Technology Inc. (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the … WebMar 25, 2024 · Vancouver, British Columbia--(Newsfile Corp. - March 25, 2024) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and ... sly cooper and the thievius raccoonus ost